Treatments

A new method enables scientists to monitor the activity of key molecules involved in the growth and remodeling of connections in the brain.

New results implicate an enzyme called ERK in the consequences of missing a segment of chromosome 16.

In May, the U.S. Food and Drug Administration guaranteed an experimental autism drug a speedy review for approval, but some scientists are skeptical of the drug’s potential.

A huge new research collaboration may jump-start the race to develop therapies for autism.

Seizures early in life may render brain circuits incapable of supporting learning during critical developmental periods.

A miniature particle delivers the gene-editing tool CRISPR into the brains of fragile X mice.

Many clinics offer neurofeedback as a therapy for autism, despite little scientific support for the technique.